Immunosuppressive microenvironment in neuroblastoma
According to the cancer immunoediting model, the interplay between tumor cells and the host immune system is crucial for the control of tumor growth. NB is a pediatric tumor that presents with metastatic disease at diagnosis in about 50% of the cases, the majority of which have poor prognosis. In th...
Main Authors: | Vito ePistoia, Fabio eMorandi, Giovanna eBianchi, Annalisa ePezzolo, Ignazia ePrigione, Lizzia eRaffaghello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00167/full |
Similar Items
-
MYCN: From Oncoprotein To Tumor-Associated Antigen
by: Vito ePistoia, et al.
Published: (2012-11-01) -
Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions
by: Shweta Joshi
Published: (2020-07-01) -
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
by: Elisa Brandetti, et al.
Published: (2017-06-01) -
BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma
by: Mehreen Ishfaq, et al.
Published: (2021-02-01) -
“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
by: Kevin X. Liu, et al.
Published: (2020-09-01)